Search - tctmd.com

Displaying 941 - 960 of 1176

Sort: Relevancy | Date

Presentation TCT 2017

Commentary II At What Point Does the Minimalist Strategy Become Ludicrous?

Presenter: Martin B. Leon

November 01, 2017

Presentation TCT 2017

Commentary I Insights From the 3M Trial

Presenter: David A. Wood

November 01, 2017

Presentation TCT 2017

Counterpoint A Customized Approach, Including General Anesthesia and TEE, Optimizes Patient Outcomes!

Presenter: Omar K. Khalique

November 01, 2017

Presentation TCT 2017

Point TAVR Without General Anesthesia and Without TEE is now the Default Strategy!

Presenter: Ganesh Manoharan

November 01, 2017

Presentation TCT 2017

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Presenter: Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Point A Balanced Look at ALL the Data Favors Cerebral Protection in ALL TAVR Patients!

Presenter: Saif Anwaruddin

November 01, 2017

Presentation TCT 2017

TAVR in Patients With Severe CKD: Diagnostic Workup, Valve Sizing, and Procedural and Post-Procedure Management

Presenter: Nirat Beohar

November 01, 2017

Presentation TCT 2017

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Presenter: Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

TAVR in AS Patients With Acute Coronary Syndromes, Left Main Disease, and Coronary Access After TAVR: Case Examples and Procedural Techniques

Presenter: James B. Hermiller Jr.

November 01, 2017

Presentation TCT 2017

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

November 01, 2017

Presentation TCT 2017

The Role of MitraClip Therapy in TAVR Patients - Treatment Paradigms (Who, When, and How) and Case Examples

Presenter: Brij Maini

November 01, 2017

Presentation TCT 2017

Frequency of MR and Clinical Management Issues in TAVR Patients

Presenter: Marco Barbanti

November 01, 2017

Presentation TCT 2017

Featured Lecture: Predictors of Mortality and Conduction Disturbances in Women Undergoing TAVR: A CT Sub-Analysis of the WIN-TAVI Registry

Presenter: Ariel Finkelstein, Ran Kornowski, Yusuke Watanabe

November 01, 2017

Presentation TCT 2017

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Philippe Genereux

November 01, 2017

Presentation TCT 2017

TAVR in Moderate Aortic Stenosis + Heart Failure: Updates From the UNLOAD Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

Etiologies and Prognosis of Secondary Tricuspid Valve Disease

Presenter: Rebecca T. Hahn, Yan Topilsky, Maurice E. Sarano

November 01, 2017

Presentation TCT 2017

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Presenter: Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Etiologies and Prognosis of Primary Tricuspid Valve Disease

Presenter: Rebecca T. Hahn, Yan Topilsky

November 01, 2017

Presentation TCT 2017

Practical Tips for TAVR in Bicuspid Aortic Valves: Device Selection, Valve Sizing and Positioning

Presenter: Didier Tchetche

November 01, 2017

Presentation TCT 2017

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Presenter: Raj Makkar

November 01, 2017

Advertisement

Commentary II At What Point Does the Minimalist Strategy Become Ludicrous?

Commentary I Insights From the 3M Trial

Counterpoint A Customized Approach, Including General Anesthesia and TEE, Optimizes Patient Outcomes!

Point TAVR Without General Anesthesia and Without TEE is now the Default Strategy!

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Point A Balanced Look at ALL the Data Favors Cerebral Protection in ALL TAVR Patients!

TAVR in Patients With Severe CKD: Diagnostic Workup, Valve Sizing, and Procedural and Post-Procedure Management

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

TAVR in AS Patients With Acute Coronary Syndromes, Left Main Disease, and Coronary Access After TAVR: Case Examples and Procedural Techniques

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

The Role of MitraClip Therapy in TAVR Patients - Treatment Paradigms (Who, When, and How) and Case Examples

Frequency of MR and Clinical Management Issues in TAVR Patients

Featured Lecture: Predictors of Mortality and Conduction Disturbances in Women Undergoing TAVR: A CT Sub-Analysis of the WIN-TAVI Registry

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

TAVR in Moderate Aortic Stenosis + Heart Failure: Updates From the UNLOAD Trial

Etiologies and Prognosis of Secondary Tricuspid Valve Disease

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Etiologies and Prognosis of Primary Tricuspid Valve Disease

Practical Tips for TAVR in Bicuspid Aortic Valves: Device Selection, Valve Sizing and Positioning

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content